Symbollon was founded in 1986 and had its initial public offering in 1993. Symbollon is leading the world in the development of products based on its molecular iodine technology. With product opportunities in two large market segments: women’s healthcare and antimicrobial applications, Symbollon is poised for explosive growth. Read on >>